Evolving Concepts in Phases I and II Drug Development for Crohn’s Disease-Reference-Cited by-同舟云学术

Evolving Concepts in Phases I and II Drug Development for Crohn’s Disease

Published:2016-08-03 Issue:2 Volume:11 Page:246-255
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Jairath Vipul,Levesque Barrett G.,Vande Casteele Niels,Khanna Reena,Mosli Mahmoud,Hindryckx Pieter,Travis Simon,Duijvenstein Marjolejn,Rimola Jordi,Panes Julian,D’Haens Geert,Sandborn William J.,Feagan Brian G.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/11/2/246/13072940/jjw137.pdf

Reference84 articles.

1. Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

2. Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

3. P176 Patient reported outcome measures derived from the Crohn's Disease Activity Index: Correlation between PRO2 and PRO3 scores and CDAI-defined clinical thresholds

4. Population pharmacokinetics of golimumab in patients with ankylosing spondylitis: impact of body weight and immunogenicity

5. The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn’s Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies;Journal of Crohn's and Colitis;2023-12-09

2. Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study;GastroHep;2023-08-25

3. MRI texture analysis of T2-weighted images is preferred over magnetization transfer imaging for readily longitudinal quantification of gut fibrosis;European Radiology;2023-04-18

4. Responsiveness of Magnetic Resonance Enterography Indices for Evaluation of Luminal Disease Activity in Crohn’s Disease;Clinical Gastroenterology and Hepatology;2022-11

5. Computed tomography enterography predicts surgical-free survival in symptomatic stricturing Crohn’s disease;Abdominal Radiology;2022-07-27